Stark D J, Manning L M, Lenton L
Med J Aust. 1981 Mar 21;1(6):275-80. doi: 10.5694/j.1326-5377.1981.tb135573.x.
The incidence of retrolental fibroplasia (RLF, retinopathy of prematurity) is increasing, as more premature infants of lower birth weight are surviving. Currently, about 17% of premature neonates at risk will develop this condition, although in 85% of these cases it will undergo spontaneous resolution. This paper reviews our current knowledge and management of RLF, and aims to remind us that sophisticated monitoring techniques have not eliminated the problems of hyperoxia.
随着越来越多低出生体重的早产儿存活下来,晶状体后纤维增生症(RLF,早产儿视网膜病变)的发病率正在上升。目前,约17%有风险的早产新生儿会患上这种疾病,不过在这些病例中,85%会自然消退。本文回顾了我们目前对RLF的认识和治疗方法,旨在提醒我们,先进的监测技术并未消除高氧问题。